These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 1289187
1. alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia. Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R. Haematologica; 1992; 77(6):502-6. PubMed ID: 1289187 [Abstract] [Full Text] [Related]
4. Alpha interferon treatment of chronic hepatitis C in beta-thalassaemia. Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R. Gut; 1993; 34(2 Suppl):S142-3. PubMed ID: 8314484 [Abstract] [Full Text] [Related]
5. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Makris M, Preston FE, Triger DR, Underwood JC, Westlake L, Adelman MI. Blood; 1991 Oct 01; 78(7):1672-7. PubMed ID: 1912556 [Abstract] [Full Text] [Related]
13. A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders. Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, Takamatsu J, Imoto M, Hayakawa T. Eur J Haematol; 1996 Aug 01; 57(2):165-70. PubMed ID: 8856094 [Abstract] [Full Text] [Related]
14. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, Nebbia G, Zancan L, De Moliner L, Bertolini A. Hepatology; 1995 Dec 01; 22(6):1623-7. PubMed ID: 7489965 [Abstract] [Full Text] [Related]
15. Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course. Reichard O, Glaumann H, Norkrans G, Wejstål R, Fryden A, Schvarcz R, Weiland O. Liver; 1994 Aug 01; 14(4):169-74. PubMed ID: 7526108 [Abstract] [Full Text] [Related]
16. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation. Van Thiel DH, Molloy PJ, Friedlander L, Kania RJ, Fagiuoli S, Caraceni P, Wright HI, Zuhdi N. Hepatogastroenterology; 1995 Aug 01; 42(6):900-6. PubMed ID: 8847043 [Abstract] [Full Text] [Related]
17. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessì C. J Pediatr; 1994 Jul 01; 125(1):123-8. PubMed ID: 8021761 [Abstract] [Full Text] [Related]
19. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. J Viral Hepat; 1995 Jul 01; 2(1):39-45. PubMed ID: 7493293 [Abstract] [Full Text] [Related]